Large-scale microarray profiling reveals four stages of immune escape in non-Hodgkin lymphomas

Quantitative FDG-PET: a new biomarker in PMBCL

(2015) M. Meignan   BLOOD

Immune checkpoint blockade in hematologic malignancies

(2015) P. Armand   BLOOD

The prognostic landscape of genes and infiltrating immune cells across human cancers

(2015) Andrew J Gentles et al.   NATURE MEDICINE

Robust enumeration of cell subsets from tissue expression profiles

(2015) Aaron M Newman et al.   NATURE METHODS

PD-1 Blockade with Nivolumab in Relapsed or Refractory Hodgkin's Lymphoma

(2015) Stephen M. Ansell et al.   NEW ENGLAND JOURNAL OF MEDICINE

Mutations in early follicular lymphoma progenitors are associated with suppressed antigen presentation

(2015) Michael R. Green et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

The Epigenetic Basis of Diffuse Large B-Cell Lymphoma

(2015) Yanwen Jiang et al.   SEMINARS IN HEMATOLOGY

The Genetic Landscape of Diffuse Large B-Cell Lymphoma

(2015) Laura Pasqualucci et al.   SEMINARS IN HEMATOLOGY

Weighted Kolmogorov Smirnov testing: an alternative for Gene Set Enrichment Analysis

(2015) Konstantina Charmpi et al.   Statistical Applications in Genetics and Molecular Biology

Weighted Kolmogorov Smirnov testing: an alternative for Gene Set Enrichment Analysis

(2015) Konstantina Charmpi et al.   Statistical Applications in Genetics and Molecular Biology

Several immune escape patterns in non-Hodgkin's lymphomas

(2015) Camille Laurent et al.   OncoImmunology

Lectin-like transcript 1 is a marker of germinal center-derived B-cell non-Hodgkin's lymphomas dampening natural killer cell functions

(2015) Claire Germain et al.   OncoImmunology

SnapShot: Diffuse Large B Cell Lymphoma

(2014) Laura Pasqualucci et al.   CANCER CELL

New insights into cancer immunoediting and its three component phases—elimination, equilibrium and escape

(2014) Deepak Mittal et al.   CURRENT OPINION IN IMMUNOLOGY

Disruption of HLA class II antigen presentation in Burkitt lymphoma: implication of a 47 000 MW acid labile protein in CD4+T-cell recognition

(2014) Jason M. God et al.   IMMUNOLOGY

Predictive value of F-18 FDG PET/CT quantization parameters in diffuse large B cell lymphoma: a meta-analysis with 702 participants

(2014) Mixue Xie et al.   MEDICAL ONCOLOGY

Genetics of Follicular Lymphoma Transformation

(2014) Laura Pasqualucci et al.   Cell Reports

Transcriptome characterization by RNA sequencing identifies a major molecular and clinical subdivision in chronic lymphocytic leukemia

(2013) P. G. Ferreira et al.   GENOME RESEARCH

Immune evasion of mantle cell lymphoma: expression of B7-H1 leads to inhibited T-cell response to and killing of tumor cells

(2013) L. Wang et al.   HAEMATOLOGICA

Curbing false discovery rates in interpretation of genome-wide expression profiles

(2013) Bernard Ycart et al.   JOURNAL OF BIOMEDICAL INFORMATICS

Safety and activity of PD1 blockade by pidilizumab in combination with rituximab in patients with relapsed follicular lymphoma: a single group, open-label, phase 2 trial

(2013) Jason R Westin et al.   LANCET ONCOLOGY

Is immune escape via human leukocyte antigen expression clinically relevant in chronic lymphocytic leukemia? Focus on the controversies

(2013) Nicolas Guillaume et al.   LEUKEMIA RESEARCH

Inferring tumour purity and stromal and immune cell admixture from expression data

(2013) Kosuke Yoshihara et al.   Nature Communications

Prognostically relevant gene signatures of high-grade serous ovarian carcinoma

(2012) Roel G.W. Verhaak et al.   JOURNAL OF CLINICAL INVESTIGATION

Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics

(2012) Roland Schmitz et al.   NATURE

Leukemia Gene Atlas – A Public Platform for Integrative Exploration of Genome-Wide Molecular Data

(2012) Katja Hebestreit et al.   PLoS One

Sample-level enrichment analysis unravels shared stress phenotypes among multiple cancer types

(2012) Gunes Gundem et al.   Genome Medicine

Molecular signatures database (MSigDB) 3.0

(2011) A. Liberzon et al.   BIOINFORMATICS

Combined Genetic Inactivation of β2-Microglobulin and CD58 Reveals Frequent Escape from Immune Recognition in Diffuse Large B Cell Lymphoma

(2011) Madhavi Challa-Malladi et al.   CANCER CELL

Genomic and phenotypic characterization of nurse-like cells that promote drug resistance in chronic lymphocytic leukemia

(2011) Loic Ysebaert et al.   LEUKEMIA & LYMPHOMA

Glucose metabolism correlated with cellular proliferation in diffuse large B-cell lymphoma

(2011) Xingchen Wu et al.   LEUKEMIA & LYMPHOMA

Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA, IDH1, EGFR, and NF1

(2010) Roel G.W. Verhaak et al.   CANCER CELL

Gene set enrichment analysis made simple

(2010) Rafael A Irizarry et al.   STATISTICAL METHODS IN MEDICAL RESEARCH

A signature-based method for indexing cell cycle phase distribution from microarray profiles

(2009) Hideaki Mizuno et al.   BMC GENOMICS

Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1

(2009) David A. Barbie et al.   NATURE

Phase I Safety and Pharmacokinetic Study of CT-011, a Humanized Antibody Interacting with PD-1, in Patients with Advanced Hematologic Malignancies

(2008) R. Berger et al.   CLINICAL CANCER RESEARCH

Programmed death 1 is a marker of angioimmunoblastic T-cell lymphoma and B-cell small lymphocytic lymphoma/chronic lymphocytic leukemia

(2008) Luc Xerri et al.   HUMAN PATHOLOGY

Stromal Gene Signatures in Large-B-Cell Lymphomas

(2008) G. Lenz et al.   NEW ENGLAND JOURNAL OF MEDICINE